Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 7, 2015, Pages 1626-1633

  Martínez Baz, Iván ^a,b   Navascués, Ana ^c   Pozo, Francisco ^d   Chamorro, Judith ^c   Albeniz, Esther ^e   Casado, Itziar ^a   Reina, Gabriel ^f   Cenoz, Manuel García ^a,b   Ezpeleta, Carmen ^c   Castilla, Jesús ^a,b   Abad, I ^g   Aldaz, P ^g   Alvarez E ^g   Arana, J J ^g   Arceiz, I ^g   Arina, E ^g   Arribas, I ^g   Artajo, M D ^g   Arza, A ^g   Azagra, B ^g   Bartolome, F C ^g   Bernues C ^g   Bolea, C ^g   Brugos, A ^g   Cano, B ^g   Castresana, M V ^g   Cenoz, J C ^g   Cia, F ^g   Compains, B ^g   Corpas, J R ^g   Cortes F ^g   Churio, B ^g   Cuevas, P C ^g   Da Costa, E M ^g   Diez Espino J ^g   Doiz, M ^g   Escribano, F J ^g   Esparza, M J ^g   Etayo, V ^g   Fernandez Alfaro C ^g   Flamarique, B ^g   Gamboa, J ^g   Garces M L ^g   Garcia Blanco L ^g   German, A B ^g   Giner, A ^g   Gomara M ^g   Goni N ^g   Guillorme, M J ^g   Guiu, J O ^g   Gurbindo, J C ^g   Guruchaga, M J ^g   Heras, J A ^g   Hijos, M C ^g   Indurain, M S ^g   Inigo B ^g   Juan Belloc, S E ^g   Jurio, J J ^g   Leon M P ^g   Longas J J ^g   Miner, J J ^g   Moreno, M ^g   Moros, M A ^g   Navarro, U ^g   Orozco, F J ^g   Orte, M ^g   Palacio, P ^g   Palau, J ^g   Perez Lecumberri C ^g   Perez Pascual, P ^g   Perez Sanz B ^g   Prado Virto, A ^g   Prado Santamaria, M ^g   Puig Arrastia, A ^g   Ridruejo, E ^g   Ramos, M ^g   Ripodas B E ^g   Rodriguez M ^g   Roncal, M A ^g   Ruiz Puertas, I ^g   Sanchez Vazquez C ^g   Sarrasqueta, P ^g   Senosiain, M A ^g   Sola, J ^g   Sota, M ^g   Ursua, M E ^g   Urtasun, I A ^g   Vigata, M J ^g   Virto, M T ^g   Vizcay, J M ^g   Artajo, P ^c   Beristain, X ^c   Bernaola, E ^c   Chamorro, J ^c   Esquiroz, M ^c   Fanlo, P ^c   Gil, F ^c   Gabari, M ^c   Hueto, J ^c   Martin C ^c   Pena L ^c   Perez C ^c   Ruiz, M ^c   Fernandez Alonso M ^f   Nunez J ^f   Garcia Irure J J ^h   Torres, M ^h   Ortega, M T ^h   Lameiro, F ⁱ   Barrado, L ⁱ   Alvarez, N ^j   Guevara, M ^a   Irisarri, F ^a   Arriazu, M ^a   Zabala, A ^a   Barricarte, A ^a   Castilla, J ^a   more..

^a INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c Universidad Pública de Navarra   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e Unidad de Patología Crónica Compleja Servicio de Pediatría y Áreas Específicas Hospital Universitario de Navarra Servicio Navarro de Salud Osasunbidea   (Spain)

^f UNIVERSITY CLINIC OF NAVARRA   (Spain)

^g Hospital Reina Sofía ^*

^h Anatomía Patológica del Hospital Reina Sofía de Tudela   (Bulgaria)

ⁱ HOSPITAL GARCÍA ORCOYEN   (Spain)

^j Servico Navarro de Salud   (Spain)

more..

Author keywords

Case control study; Effectiveness; Influenza; Influenza B virus; Influenza vaccine; Sentinel surveillance

Indexed keywords

INFLUENZA VACCINE; VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FLU LIKE SYNDROME; GENE; HAEMAGGLUTININ GENE; HOSPITAL PATIENT; HUMAN; INFLUENZA A; INFLUENZA B; INFLUENZA B VIRUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT; PHYLOGENY; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; CASE CONTROL STUDY; ELECTRONIC HEALTH RECORD; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ODDS RATIO; PATHOGENICITY; SEASON; SENTINEL SURVEILLANCE; SPAIN; TIME FACTOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INPATIENTS; MALE; MIDDLE AGED; ODDS RATIO; OUTPATIENTS; SEASONS; SENTINEL SURVEILLANCE; SPAIN; TIME FACTORS; VACCINE POTENCY; YOUNG ADULT;

EID: 85000542365     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1038002     Document Type: Article

References (31)

1. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the communitydwelling elderly. N Engl J Med 2007; 357:1373-81; PMID:17914038; http://dx. doi. org/10. 1056/ NEJMoa070844
2. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012; 12:36-44; PMID:22032844; http://dx. doi. org/ 10. 1016/S1473-3099(11)70295-X
3. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010; 28:2149-56; PMID:20003926; http://dx. doi. org/10. 1016/j. vaccine. 2009. 11. 068
4. Skowronski DM, De Serres G, Dickinson J, Petric M, Mak A, Fonseca K, Kwindt TL, Chan T, Bastien N, Charest H, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:168-79; PMID:19086914; http://dx. doi. org/10. 1086/595862
5. World Health Organization. Recommended composition of the influenza virus vaccines for use in the 2012- 2013 northern hemisphere influenza season. Wkly Epidemiol Rec 2012; 87:83-95; PMID:22462202
6. Sistema de Vigilancia de la Gripe en España. Informe semanal 5/2013. [Report of the influenza surveillance system in Spain 5/2013]. No 337. 7 February 2013. Spanish. Available from: http://vgripe. isciii. es/gripe/ documentos/20122013/boletines/grn0513. pdf
7. Castilla J, Martínez-Baz I, Martinez-Artola V, Fernandez- Alonso M, Reina G, Guevara M, Garcia Cenoz M, Elia F, Alvarez N, Barricarte A, et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/ 13 mid-season analysis. Euro Surveill 2013; 18:2; PMID:23449182
8. Torner N, Martínez A, Basile L, Marcos MA, Antón A, Mar Mosquera M, Isanta R, Cabezas C, Jané M, Domínguez A, Program Of Catalonia TP. Influenza vaccine effectiveness assessment through sentinel virological data in three post-pandemic seasons. Hum Vaccin Immunother 2015; 11:225-30; PMID:25483540.
9. McLean HQ, Thompson MG, Sundaram ME, Kieke BA, Gaglani M, Murthy K, Piedra PA, Zimmerman RK, Nowalk PK, Raviotta JM, et al. Influenza Vaccine Effectiveness in the United States During. 2012-13: Variable Protection by Age and Virus Type. J Infect 405 Dis 2015; 211:1529-40; PMID:25406334
10. Lo YC, Chuang JH, Kuo HW, HuangWT, Hsu YF, Liu MT, Chen CH, HuangHH, Chang CH, Chou JH, et al. Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/ Yamagata-lineage viruses in Taiwan, 2011-12 season. PLoS One 2013; 8:e58222; PMID:23472161; http://dx. doi. org/10. 1371/journal. pone. 0058222
11. Puig-Barberà J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, Buiques-Vila A, Martínez-Vbeda S, Sominina A; GIHSN Group. 2012-2013 seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network. PLoS One 2014; 9:e100497; PMID:24945510; http://dx. doi. org/10. 1371/journal. pone. 0100497
12. Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano, de Gaetano Donati K, Galtier F, Hak E, Guevara M, Constanzo S, et al. European hospital IVE network. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A (H3N2) and B: estimates from a European network of hospitals. Euro Surveill 2015; 20: pii=21011; PMID:25613779
13. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, Rogalska J, Pitigoi D, Paradowska- Stankiewicz I, Reuss A, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill 2014; 19. pii: 20701; PMID:24556348
14. Instituto de Salud Carlos III. Informe de Vigilancia de la Gripe en España. Temporada 2012-2013 (Desde la semana 40/2012 hasta la semana 20/2013). [Report of the influenza surveillance system in Spain. 2012-2013 season]. Sistema de Vigilancia de la Gripe en España. Spanish. Available from: http://vgripe. isciii. es/gripe/ documentos/20122013/InformesAnuales/Informe_Vi gilancia_GRIPE_2012-13_18sep2013. pdf
15. Snacken R, Broberg E, Beauté J, Lozano JE, Zucs P, Amato-Gauci AJ. Influenza season 2012-2013 in Europe: moderate intensity, mixed (sub)types. Epidemiol Infect 2014; 142:1809-12; PMID:24814635; http://dx. doi. org/10. 1017/S0950268814001228
16. European Centre for Disease Prevention and Control. Surveillance Report: Influenza virus characterisation. Stockholm: ECDC; Summary Europe, July 2013. Available from: http://www. ecdc. europa. eu/en/publica tions/Publications/influenza-virus-characterisation- July-2013. pdf
17. Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. Clin Infect Dis 2014; 59:1519-24; PMID:25139969; http://dx. doi. org/10. 1093/cid/ciu664
18. Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, et al. Low 2012-13 influenza vaccine effectiveness associated with mutation in the eggadapted H3N2 vaccine strain not antigenic drift in circulating viruses. PLoS One 2014; 9:e92153; PMID:24667168; http://dx. doi. org/10. 1371/journal. pone. 0092153
19. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, Belongia EA. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 2014; 59:1375-85; PMID:25270645; http://dx. doi. org/10. 1093/cid/ciu680
20. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010; 28 (Suppl 4):D45- 53; PMID:20713260; http://dx. doi. org/10. 1016/j. vaccine. 2010. 08. 028
21. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8; PMID:22226861; http://dx. doi. org/ 10. 1016/j. vaccine. 2011. 12. 098
22. Bresee J, Hayden FG. Epidemic influenza-responding to the expected but unpredictable. N Engl J Med 2013; 368:589-92; PMID:23343038; http://dx. doi. org/ 10. 1056/NEJMp1300375
23. Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health 2013; 103:e43-51; PMID:23327249; http://dx. doi. org/10. 2105/AJPH. 2012. 301137
24. Martínez-Baz I, Martínez-Artola V, Reina G, Guevara M, Cenoz MG, Morán J, Irisarri F, Arriazu M, Castilla J. Primary Health Care Sentinel Network of Navarre. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study. BMC Public Health 2013; 13:191; PMID:23496887; http://dx. doi. org/10. 1186/ 1471-2458-13-191
25. Castilla J, Martínez-Baz I, Martínez-Artola V, Reina G, Pozo F, García Cenoz M, Guevara M, Morán J, Irisarri F, Arriazu M, et al. Primary Health Care Sentinel Network; Network for Influenza Surveillance in Hospitals of Navarre. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013; 18. pii: 20388; PMID:23399423
26. Castilla J, Martínez-Artola V, Salcedo E, Martínez-Baz I, Cenoz MG, Guevara M, Alvarez N, Irisarri F, Morán J, Barricarte A. Network for Influenza Surveillance in Hospitals of Navarre. Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010- 2011: cohort and case-control study. Vaccine 2012; 30:195-200; PMID:22100636; http://dx. doi. org/ 10. 1016/j. vaccine. 2011. 11. 024
27. Aguilar I, Reyes M, Martinez-Baz I, Guevara M, Albeniz E, Belza MJ, Castilla J. Use of the vaccination register to evaluate influenza vaccine coverage in seniors in the 2010/11 influenza season, Navarre, Spain. Euro Surveill 2012; 17:pii=20154; PMID:22551499
28. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioners networks. Vaccine 2010; 28:7381-8; PMID:20851086; http://dx. doi. org/10. 1016/j. vaccine. 2010. 09. 010
29. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 2006; 35: 337-44; PMID:16368725; http://dx. doi. org/10. 1093/ ije/dyi274
30. De Serres G, Skowronski DM, Wu XW, Ambrose CS. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 2013; 18. pii: 20585; PMID: 24079398
31. Foppa IM, Haber M, Ferdinands JM, Shay DK. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013; 31:3104-9; PMID:23624093; http://dx. doi. org/10. 1016/j. vaccine. 2013. 04. 026